Home/ Stocks/ VCYT

Veracyte, Inc.

VCYT XNAS

$40.42 -0.37 (-0.91%) ▼ 15-min delayed

Open

$40.76

High

$41.03

Low

$38.71

Volume

1.16M

Market Cap

$3.23B

About Veracyte, Inc.

Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder).

Sector: SERVICES-MEDICAL LABORATORIES Employees: 755 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	$139.07M	$28.71M	$0.36
FY 2025	$517.14M	$66.35M	$0.84
Q3 2025	$131.87M	$19.14M	$0.24
Q2 2025	$130.16M	$-980,000	$-0.01

Earnings & Analyst Ratings

Next Earnings: Tue, Aug 4, 2026

Calendar →

Related Market News

No specific coverage for VCYT yet. Check out our latest market news or earnings calendar.

Get VCYT Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Veracyte, Inc..

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.